Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient
โ Scribed by Osama Gheith; Adel Bakr; Ehab Wafa; Ashraf Fouda; Amgad El Agroudy; Ayman Refaie; Ahmed Donia; Alaa Sabry; Mohamed Sobh; Ahmed Shokeir; Mohamed Ghoneim
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 287 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1342-1751
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Kaposi's sarcoma (KS) is a low-grade vascular neoplasm associated with human herpesvirus-8 (HHV-8) infection that develops in 0.1% to 5% of transplant recipients. 1 A recent multicenter Italian survey showed an approximately 100 times greater risk for KS in organ transplant recipients versus the gen
Kaposi's sarcoma (KS) is a common malignancy in patients with acquired immunodeficiency syndrome (AIDS), classically appearing as red to purple plaques containing small papules and nodules. We report our experience with an adolescent orthotopic liver transplant recipient who presented with an unusua
Dermatological complications following transplantation are very common and the majority of immunosuppressed transplant recipients develop some to many warts due to human papillomavirus (HPV) infection. In the setting of immunosuppression, therapeutic management may be disappointing because of the ex